Journals / International Journal of Chemistry and Technology / 2021 / Cilt: 5 - Sayı: 2

Structural and spectral properties of 4-(4-(1-(4-Hydroxyphenyl)-1-phenylethyl)phenoxy)phthalonitrile: Analysis by TD-DFT method, ADME analysis and docking studies

Pages
147–155
Publication Date
2021-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, molecular docking studies were performed for two compounds separately with three different enzymes (AchE, BchE, α-GLY), and docking scores and receptor models were presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since phthalonitrile compounds have become popular lately, the focus has been on the idea that these compounds should be investigated.
📊
Key Findings & Data:A unique phthalonitrile compound, 4-(4-(1-(4-hydroxyphenyl)-1-phenylethyl)phenoxy)phthalonitrile (coded as PN) was selected and molecular modeling studies were carried out on this compound to be brought to the literature.
💡
Conclusion & Impact:Finally, molecular docking studies were performed for two compounds separately with three different enzymes (AchE, BchE, α-GLY), and docking scores and receptor models were presented.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Phthalonitrile · TD-DFT · ADMET

Abstract

Since phthalonitrile compounds have become popular lately, the focus has been on the idea that these compounds should be investigated. A unique phthalonitrile compound, 4-(4-(1-(4-hydroxyphenyl)-1-phenylethyl)phenoxy)phthalonitrile (coded as PN) was selected and molecular modeling studies were carried out on this compound to be brought to the literature. First, time-dependent density functional theory (TD-DFT) calculations (Geometry optimization, HOMO-LUMO, dipole moment calculations, MEPS maps, Mulliken atomic charges, and NBO analysis) were performed for PN. In addition, in this section, absorption, distribution, metabolism, excretion, and toxicity (ADMET) analysis for the compound belonging to the phthalonitrile group was performed and the color regions were presented separately. Finally, molecular docking studies were performed for two compounds separately with three different enzymes (AchE, BchE, α-GLY), and docking scores and receptor models were presented.

🔖

Cite This Article

ALTUN, K., YILDIKO, Ü., TANRIVERDİ, A. A., ÇAKMAK, İ. (2021). Structural and spectral properties of 4-(4-(1-(4-Hydroxyphenyl)-1-phenylethyl)phenoxy)phthalonitrile: Analysis by TD-DFT method, ADME analysis and docking studies. International Journal of Chemistry and Technology, Cilt: 5 - Sayı: 2, 147–155. https://ajindex.com/articles/765649

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (23)

  1. Derradji, M.; Ramdani, N.; Zhang, T; Wang, J.; Gong, L-d.; Xu, X-d.; Lin, Z-w;. Henniche, A.; Rahoma, H.K.S.; Liu. W-b Prog. Org. Coat. 2016, 90, 34-43
  2. Dominguez, D.D.; Keller, T.M. Polymer. 2007, 48, 91-97
  3. Keller, T.M. J Polym. Sci. A Polym. Chem. 1988, 26, 3199-3212
  4. Tomoda, H.; Saito, S.; Ogawa, S.; Shiraishi, S. Chem. Lett. 1980, 9, 1277-1280
  5. Derradji, M.; Wang, J.; Liu, W. In Phthalonitrile Resins and Composites, Eds.: William Andrew Publishing, 2018, pp 107-174
  6. Derradji, M.; Wang, J.; Liu, W. In Phthalonitrile Resins and Composites, Eds.: William Andrew Publishing, 2018, pp 175-239
  7. Sastri, S.B.; Keller, T.M. J Polym. Sci. A Polym. Chem. 1998, 36, 1885-1890
  8. Keller, T.M.; Dominguez, D.D. Polymer. 2005, 46, 4614-4618
  9. Brunovska, Z.; Ishida, H. J. Appl. Polym. Sci. 1999, 73, 2937-2949
  10. Hardin, C.; Pogorelov, T.V.; Luthey-Schulten, Z. Curr. Opin. Struct. Biol. 2002, 12, 176-181
  11. Warzel, M.L.; Keller, T.M. Polymer. 1993, 34, 663-666
  12. Brémond, É.A.G.; Kieffer, J.; Adamo, C. J. Mol. Struct. THEOCHEM. 2010, 954, 52-56
  13. Guillaumont, D.; Nakamura, S. Dyes. Pigm. 2000, 46, 85-92
  14. Gilad, Y;. Senderowitz, H. J. Chem. Inf. Model. 2014, 54, 96-107
  15. Ekins, S.; Waller, C.L.; Swaan, PW.; Cruciani, G.; Wrighton, S.A.; Wikel, J.H. J. Pharmacol. Tox. Met. 2000, 44, 251-272
  16. Kaya, E.D.; Türkhan, A.; Gür, F.; Gür, B. J. Biomol. Struct. Dyn. 2021, 1-14
  17. Yıldıko, Ü.; Ata, A. Ç.; Tanriverdi, A. A.; Çakmak, İ. Bull. Mater. Sci. 2021, 44, 186
  18. Ağırtaş, M.S.; Cabir, B; Yıldıko, Ü.; Özdemir, S.; Gonca, S. Chem. Pap. 2021, 75, 1749-1760
  19. Güngördü, Solğun, D.; Yıldıko, Ü.; Özkartal, A.; Ağırtaş, M.S. Chem. Pap. 2021, 20. Bhuvaneswari, R.; Bharathi, MD.; Anbalagan, G.; Chakkaravarthi, G.; Murugesan, K.S. J. Mol. Struct. 2018, 1173, 188-195
  20. Vanasundari, K.; Balachandran, V.; Kavimani, M.; Narayana, B. J. Mol. Struct. 2017, 1147, 136-147
  21. Tuntland, T.; Ethell, B.; Kosaka, T.; Blasco, F.; Zang, RX.; Jain, M.; Gould, T.; Hoffmaster, K. Front. Pharmacol. 2014, 5, 174
  22. Adiguzel, R.; Türkan, F.; Yildiko, Ü.; Aras, A.; Evren, E.; Onkol, T. J. Mol. Struct. 2021, 1231, 129943
  23. Aras, A.; Türkan, F.; Yildiko, U.; Atalar, M.N.; Kılıç, Ö.; Alma, M.H.; Bursal, E. Chem. Pap. 2021, 75, 1133-1146.